Royce & Associates LP Charles River Laboratories International, Inc. Transaction History
Royce & Associates LP
- $9.25 Billion
- Q2 2025
A detailed history of Royce & Associates LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Royce & Associates LP holds 85,640 shares of CRL stock, worth $15.2 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
85,640
Previous 4,140
1968.6%
Holding current value
$15.2 Million
Previous $623,000
1985.71%
% of portfolio
0.14%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
616Shares Held
53.2MCall Options Held
1.42MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA5.81MShares$1.03 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$902 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA3.77MShares$668 Million0.11% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$406 Million0.63% of portfolio
-
State Street Corp Boston, MA1.86MShares$330 Million0.01% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.02B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...